Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-08

FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)